ChronoScale Holdings Corporation (CHRN) Financials
Ticker history: EKSO became CHRN (ChronoScale Holdings Corporation) on . Earlier news and filings retain their original names and dates. View EKSO history.
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 30, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q1 FY2027, filed Oct 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CHRN SEC filings page.
ChronoScale Holdings Corporation (CHRN) reported $12.8M in revenue for fiscal year 2026, down 84.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
ChronoScale’s balance sheet expanded dramatically, but current obligations exceed current assets while losses still consume operating cash.
In FY2026, asset growth was balance-sheet-led rather than revenue-led: total assets reached$325.9M against revenue of$12.8M . Goodwill of$54.5M alongside reported ROA of-3.6% means the enlarged asset base is not yet producing positive earnings.
Short-term financing is the immediate structural strain: current liabilities reached
Accounting losses are translating almost directly into cash outflow: FY2026 operating cash flow was
Financial Health Signals
Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of ChronoScale Holdings Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
ChronoScale Holdings Corporation held $9.7M in cash, cash equivalents and investments at the end of fiscal year 2026, and its operations used $11.8M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and ChronoScale Holdings Corporation scores 31/100 among other emerging companies.
ChronoScale Holdings Corporation had 146M shares outstanding at the end of fiscal year 2026. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and ChronoScale Holdings Corporation scores 7/100 among other emerging companies.
ChronoScale Holdings Corporation spent $3.0M on research and development in fiscal year 2026, which was 11.6% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and ChronoScale Holdings Corporation scores 39/100 among other emerging companies.
ChronoScale Holdings Corporation reported revenue of $12.8M in fiscal year 2026, against $84.4M in fiscal year 2025. Revenue Progress ranks emerging companies on the three-year path of that line, and ChronoScale Holdings Corporation scores 23/100 among other emerging companies.
ChronoScale Holdings Corporation's operations used $11.8M of cash in fiscal year 2026, against $9.8M used in fiscal year 2025. Burn Trend ranks emerging companies on which way that figure has moved over three years, and ChronoScale Holdings Corporation scores 49/100 among other emerging companies.
ChronoScale Holdings Corporation's cash, cash equivalents and investments came to $9.7M at the end of fiscal year 2026, against $143.8M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and ChronoScale Holdings Corporation scores 13/100 among other emerging companies.
ChronoScale Holdings Corporation scores 7.63, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $2.1B against total liabilities of $143.8M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
ChronoScale Holdings Corporation passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
ChronoScale Holdings Corporation reported a net loss of $11.7M while operations used $11.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.
ChronoScale Holdings Corporation reported an operating loss of $13.3M against $309K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
ChronoScale Holdings Corporation generated $41.5M in revenue in Q1 2027. This represents an increase of 1837.5% from the same quarter a year earlier.
ChronoScale Holdings Corporation's EBITDA was -$9.5M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
ChronoScale Holdings Corporation reported a net loss of $42.5M in Q1 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
ChronoScale Holdings Corporation earned -$0.29 per diluted share (EPS) in Q1 2027.
Cash & Balance Sheet
ChronoScale Holdings Corporation generated $11.6M in free cash flow in Q1 2027, representing cash available after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
ChronoScale Holdings Corporation held $15.2M in cash against $151K in long-term debt as of Q1 2027, with $101.2M of liabilities due within a year.
Not reported for Q1 2027.
Margins & Returns
ChronoScale Holdings Corporation's gross margin was -10.0% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is down 60.2 percentage points from the same quarter a year earlier.
ChronoScale Holdings Corporation's operating margin was -60.0% in Q1 2027, reflecting core business profitability. No change is given against Q1 2026: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
ChronoScale Holdings Corporation's quarterly ROE was -28.2% in Q1 2027: one quarter's net income over shareholder equity, not annualized. This is up 301.2 percentage points from the same quarter a year earlier.
Not shown for Q1 2027: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
ChronoScale Holdings Corporation invested $3.1M in capex in Q1 2027, funding long-term assets and infrastructure. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Not reported for Q1 2027.
Not reported for Q1 2027.
CHRN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q1'2610-Q | Q4'2510-Q | Q1'2610-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $41.5M+1837.5% | N/A | $2.1M-36.6% | N/A | $16.7M+395.3% | $2.1M-58.4% | $3.4M-10.1% | $74.8M+1443.5% |
| Cost of Revenue | $45.6M+4176.3% | N/A | $1.1M-32.0% | N/A | $1.7M+6.9% | $1.2M-46.5% | $1.6M-13.1% | $3.7M+48.8% |
| Gross Profit | -$4.1M-486.0% | N/A | $1.1M-40.5% | N/A | $2.5M+41.1% | $819K-68.9% | $1.8M-7.4% | $4.7M+97.4% |
| R&D Expenses | N/A | N/A | $583K-41.0% | N/A | $550K-44.3% | $852K-23.7% | $988K-13.0% | $1.3M-4.3% |
| SG&A Expenses | $20.7M+239.5% | N/A | $6.1M+43.5% | N/A | $383K-91.0% | $3.9M+2.2% | $4.3M+4.6% | $12.5M+178.5% |
| Operating Income | -$24.9Mn/m | N/A | -$5.6Mn/m | N/A | -$1.4Mn/m | -$4.0Mn/m | -$3.4Mn/m | -$406Kn/m |
| EBITDA | -$9.5Mn/m | N/A | -$5.2Mn/m | N/A | $13.1Mn/m | -$3.6Mn/m | -$3.1Mn/m | $40Kn/m |
| Interest Expense | $1.6M+994.4% | N/A | $143K+98.6% | N/A | $18K-75.0% | $65K-12.2% | $72K+26.3% | $53K-18.5% |
| Net Income | -$42.5Mn/m | N/A | -$6.9Mn/m | N/A | -$1.4Mn/m | -$2.7Mn/m | -$2.9Mn/m | -$3.7Mn/m |
| EPS (Basic) | -$0.29 | N/A | -$2.04 | -$1.56 | -$0.54 | -$1.24 | -$1.84 | -$2.06 |
| EPS (Diluted) | -$0.29 | N/A | -$2.04 | -$1.56 | -$0.54 | -$1.24 | -$1.84 | -$2.06 |
| Diluted Shares (Avg) | 145M | N/A | N/A | N/A | 138M | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Income Tax.
CHRN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q1'2610-Q | Q4'2510-Q | Q1'2610-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $295.4M+1402.0% | $325.9M+1520.4% | $19.7M-28.0% | $20.1M-24.5% | $21.7M-20.7% | $23.2M-14.1% | $27.3M-5.7% | $26.7M-7.8% |
| Current Assets | $30.7M+118.4% | $44.2M+214.9% | $14.1M-30.0% | $14.0M-25.4% | $14.8M-26.3% | $16.0M-14.3% | $20.1M-2.2% | $18.8M-6.8% |
| Cash & Equivalents | $15.2M+281.2% | $9.7M+726.7% | $4.0M-50.4% | $1.2M-74.0% | $2.7M-66.2% | $5.2M-10.9% | $8.1M-8.5% | $4.5M-48.0% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | N/A | N/A | $4.6M-6.3% | $4.8M+5.5% | $5.0M+1.2% | $5.4M+9.3% | $5.0M-2.8% | $4.6M-9.5% |
| Accounts Receivable | $7.6M+66.6% | $12.5M+71.6% | $4.5M-29.7% | $7.3M+1.0% | $6.0M-6.3% | $4.5M-30.5% | $6.5M-10.8% | $7.2M+28.2% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $54.4M+12518.8% | $54.5M+12548.0% | $431K0.0% | $431K0.0% | $431K0.0% | $431K0.0% | $431K0.0% | $431K0.0% |
| Total Liabilities | $144.8M+939.3% | $143.8M+1197.7% | $13.9M-4.7% | $11.1M-20.5% | $12.0M-18.0% | $12.2M-18.0% | $14.6M-1.9% | $13.9M-14.5% |
| Current Liabilities | $101.2M+1012.9% | $86.9M+906.1% | $9.1M+6.3% | $8.6M+14.6% | $8.9M+4.5% | $6.7M-12.9% | $8.6M+17.0% | $7.5M-7.1% |
| Non-Current Liabilities | $43.6M+801.0% | $56.9M+2226.2% | $4.8M-20.2% | $2.4M-61.8% | $3.0M-49.8% | $5.5M-23.5% | $6.1M-20.1% | $6.4M-21.8% |
| Long-Term Debt | $151K | $474K | N/A | N/A | N/A | $12.0M | N/A | N/A |
| Total Equity | $150.7M+7108.1% | $180.0M+1894.3% | $2.1M-83.5% | $9.0M-29.0% | $9.7M-23.7% | $10.9M-9.4% | $12.7M-9.7% | $12.7M+0.8% |
| Retained Earnings | -$241.9Mn/m | -$199.5Mn/m | -$269.3Mn/m | -$262.4Mn/m | -$257.7Mn/m | -$256.3Mn/m | -$253.6Mn/m | -$250.5Mn/m |
CHRN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q1'2610-Q | Q4'2510-Q | Q1'2610-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $14.6Mn/m | N/A | -$2.1Mn/m | -$4.3Mn/m | $95Kn/m | -$3.4Mn/m | -$2.0Mn/m | -$1.4Mn/m |
| Depreciation & Amortization | $15.3M+3278.4% | N/A | $454K+20.1% | $451K+13.3% | $14.5M+3732.3% | $377K-5.0% | $378K-6.9% | $398K-7.9% |
| Stock-Based Compensation | $10.1M+8784.2% | N/A | $114K-54.4% | N/A | $90K-64.0% | $207K-27.4% | $250K-33.5% | N/A |
| Capital Expenditures | $3.1Mn/m | N/A | $0-100.0% | $126K+500.0% | $12K+20.0% | $40Kn/m | $10K+25.0% | $21K-51.2% |
| Free Cash Flow | $11.6Mn/m | N/A | -$2.1Mn/m | -$4.5Mn/m | $83Kn/m | -$3.5Mn/m | -$2.0Mn/m | -$1.5Mn/m |
| Investing Cash Flow | -$3.1Mn/m | N/A | $0n/m | -$126Kn/m | -$977Kn/m | -$40Kn/m | -$10Kn/m | -$21Kn/m |
| Financing Cash Flow | -$6.0M-221.3% | N/A | $5.0M+40.3% | $2.9Mn/m | -$1.5M-142.8% | $616Kn/m | $3.5M-3.5% | -$314K-190.2% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
CHRN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q1'2610-Q | Q4'2510-Q | Q1'2610-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -10.0%-60.2pp | N/A | 50.2%-3.3pp | N/A | 15.3%-38.3pp | 39.8%-13.4pp | 53.5%+1.6pp | 6.3%-42.6pp |
| Operating Margin | -60.0% | N/A | -262.4% | N/A | -8.4% | -193.2% | -101.9% | -0.5%+70.6pp |
| Net Margin | -102.4% | N/A | -321.6% | N/A | -8.5%+77.2pp | -131.7% | -85.7%+5.6pp | -4.9%+61.4pp |
| Return on Equity | -28.2%+301.2pp | N/A | -329.4%-306.6pp | N/A | -14.7%+8.1pp | -24.8%-4.7pp | -22.8%+1.6pp | -28.8%-3.3pp |
| Return on Assets | -14.4%+20.6pp | N/A | -35.0%-24.4pp | N/A | -6.6%+4.0pp | -11.7%-2.7pp | -10.6%+1.3pp | -13.7%-2.6pp |
| Current Ratio | 0.30-1.2x | 0.51-1.1x | 1.55-0.8x | 1.63-0.9x | 1.66-0.7x | 2.380.0x | 2.35-0.5x | 2.500.0x |
| Debt-to-Equity | 0.00 | 0.00 | N/A | N/A | N/A | 1.10 | N/A | N/A |
| Liabilities-to-Equity | 0.96-5.7x | 0.80-0.4x | 6.66+5.5x | 1.23+0.1x | 1.24+0.1x | 1.12-0.1x | 1.15+0.1x | 1.10-0.2x |
| Asset Turnover | 0.140.0x | N/A | 0.110.0x | N/A | 0.77+0.6x | 0.09-0.1x | 0.120.0x | 2.81+2.6x |
| FCF Margin | 27.9%+127.0pp | N/A | -99.2%-40.6pp | N/A | 0.5%+59.0pp | -169.4% | -58.5%+34.0pp | -1.9%+31.6pp |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Note: The current ratio is below 1.0 (0.51), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| ChronoScale Holdings Corporation CHRN | FY2026 | $12.8M | -$11.7M | -91.4% | $2.1B | 27/100 |
| Pony AI Inc. PONY | FY2025 | $90.0M | -$134.0M | N/A | $2.0B | 64/100 |
| Globant S.A. GLOB | FY2025 | $2.5B | $102.9M | 4.2% | $2.0B | 64/100 |
| DXC Technology Company DXC | FY2026 | $12.6B | $18.0M | 0.1% | $2.3B | 53/100 |
| Penguin Solutions, Inc. PENG | FY2026 | $1.7B | $180.6M | 10.4% | $2.7B | 55/100 |
Where ChronoScale Holdings Corporation Ranks
Frequently Asked Questions
ChronoScale Holdings Corporation (CHRN) reported $12.8M in total revenue for fiscal year 2026. This represents a -84.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
ChronoScale Holdings Corporation (CHRN) revenue declined by 84.8% year-over-year, from $84.4M to $12.8M in fiscal year 2026.
No, ChronoScale Holdings Corporation (CHRN) reported a net loss of $11.7M in fiscal year 2026, with a net profit margin of -91.4%.
ChronoScale Holdings Corporation (CHRN) had EBITDA of -$11.8M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2026, ChronoScale Holdings Corporation (CHRN) had $9.7M in cash and equivalents against $474K in long-term debt.
ChronoScale Holdings Corporation (CHRN) had a gross margin of 53.5% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
ChronoScale Holdings Corporation (CHRN) had a net profit margin of -91.4% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
ChronoScale Holdings Corporation (CHRN) has a return on equity of -6.5% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
ChronoScale Holdings Corporation (CHRN) recorded an outflow of $12.0M in free cash flow during fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
ChronoScale Holdings Corporation (CHRN) recorded an outflow of $11.8M in operating cash flow during fiscal year 2026, representing cash used by core business activities.
ChronoScale Holdings Corporation (CHRN) had $325.9M in total assets as of fiscal year 2026, including both current and long-term assets.
ChronoScale Holdings Corporation (CHRN) invested $188K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
ChronoScale Holdings Corporation (CHRN) invested $3.0M in research and development during fiscal year 2026.
ChronoScale Holdings Corporation (CHRN) had a current ratio of 0.51 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.
ChronoScale Holdings Corporation (CHRN) had a debt-to-equity ratio of 0.00 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
ChronoScale Holdings Corporation (CHRN) had a liabilities-to-equity ratio of 0.80 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
ChronoScale Holdings Corporation (CHRN) had a return on assets of -3.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
ChronoScale Holdings Corporation (CHRN) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2026). The market capitalization is $2.1B as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
ChronoScale Holdings Corporation (CHRN) trades at 164x sales, its market capitalization divided by $12.8M revenue, FY2026. The market capitalization is $2.1B as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2026, ChronoScale Holdings Corporation (CHRN) held $9.7M in cash, cash equivalents and investments, and reported an operating cash outflow of $11.8M over that year. Dividing the one by the other, the reported balance equals about 10 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
ChronoScale Holdings Corporation (CHRN) has an Altman Z-Score of 7.63, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
ChronoScale Holdings Corporation (CHRN) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
ChronoScale Holdings Corporation (CHRN) reported a net loss of $11.7M while operations used $11.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
ChronoScale Holdings Corporation (CHRN) reported an operating loss of $13.3M against $309K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
ChronoScale Holdings Corporation (CHRN) scores 27 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.